HAMP and metabolic dysfunction-associated steatotic liver disease: Therefore, serum hepcidin in patients with MASLD is higher compared to non-MASLD individuals, while the increase in serum hepcidin results in a decrease in ferroportin expression and cellular iron output, which further induces iron deposition in hepatocytes [154].